+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4591310
  • Report
  • June 2020
  • Region: Global
  • 114 Pages
  • Mordor Intelligence


  • Abbott
  • Beckman Coulter Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson and Johnson
  • Nova Biomedical
  • Qiagen
The point-of-care diagnostics market is expected to register a CAGR of 9.8%, over the forecast period. One of the major factors responsible for the growth of the market is the rising prevalence of chronic and infectious diseases in developing economies. The prevalence of chronic diseases, like diabetes, rheumatism, or cancer, is increasing globally, due to various reasons, such as an increase in the geriatric population, sedentary lifestyles, unhealthy food habits, and environmental factors. For instance, chronic diseases kill more than 38 million people each year, globally. Cardiovascular diseases account for most chronic disease deaths, or 17.5 million people, annually, followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). The aforementioned diseases account for 82% of all chronic disorder deaths. Point-of-care diagnostics is gaining wide acceptance by different patients across the world, as samples are collected from the patient’s location for performing tests, and the results can be achieved in very less time, due to the use of micro fluids, chips, and nano diagnostics.

Factors, such as the increasing number of regulatory approvals for novel immunoassay techniques, technological advancements, and the rising usage of home-based POC devices, are expected to drive the market growth, over the forecasted period.

Key Market Trends

Blood Glucose Testing is Expected to Hold Major Revenue Share in the Type of Product Segment

Blood glucose testing point-of-care diagnostics captured the largest share in 2019, due to the success of hand-held glucose meters, owing to their high adoption rate among the population across the world. Periodic monitoring of glucose level is of vital importance for diabetic patients, which has encouraged the adoption of POC among diabetic patients in this segment. Other advantages associated with hand-held glucose meters are the portability and easy operability. The rising prevalence of diabetes across the world is expected to boost the segment growth in the future.

North America Dominates the Market and is Expected to do Same in the Forecast Period

Currently, North America dominates the market for point-of care-diagnostics, and is expected to continue its stronghold for a few more years. In the North America region, the United States holds the largest market share. This can be majorly attributed due to the growing geriatric population base in the country, as well as the factors, such as the increasing prevalence of diseases and the favorable government regulations and initiatives undertaken for the development of healthcare infrastructure.

Competitive Landscape

The point-of-care diagnostics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With rising prevalence of diseases and increasing number of aging population, other players are also expected to enter the market. Some of the major players of the market are Abbott, Siemens AG, Becton, Dickinson and Company, Johnson and Johnson, and F. Hoffmann-La Roche Ltd, among others.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Abbott
  • Beckman Coulter Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson and Johnson
  • Nova Biomedical
  • Qiagen

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic and Infectious Diseases in Developing Economies
4.2.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques
4.2.3 Technological Advancements
4.2.4 Rising Usage of Home-based POC Devices
4.3 Market Restraints
4.3.1 Product Recalls by Major Players Demotivate New Entrants
4.3.2 Stringent Regulatory Policies and Reimbursement Issues
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Glucose Monitoring Kit
5.1.2 Cardio-metabolic Monitoring Kit
5.1.3 Pregnancy and Fertility Testing Kit
5.1.4 Infectious Disease Testing Kit
5.1.5 Cholesterol Test Strip
5.1.6 Hematology Testing Kit
5.1.7 Other Products
5.2 By End User
5.2.1 Hospital/Critical Care Setting
5.2.2 Ambulatory Care Setting
5.2.3 Research Laboratory
5.2.4 Other End Users
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Abbott
6.1.2 Siemens AG
6.1.3 Beckman Coulter Inc.
6.1.4 Becton, Dickinson and Company
6.1.5 Instrumentation Laboratory
6.1.6 Johnson and Johnson
6.1.7 Nova Biomedical
6.1.8 Qiagen
6.1.9 F. Hoffmann-La Roche Ltd
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott
  • Siemens AG
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • Instrumentation Laboratory
  • Johnson and Johnson
  • Nova Biomedical
  • Qiagen
  • F. Hoffmann-La Roche Ltd
Note: Product cover images may vary from those shown